FDA calls for audits of heparin suppliers in draft guidance
The FDA is asking companies to audit heparin suppliers in draft guidance intended to stop a repeat of the 2008 contamination.
The FDA is asking companies to audit heparin suppliers in draft guidance intended to stop a repeat of the 2008 contamination.
Agilent has introduced a compliance service to cut the time take to validate and begin production at cGMP laboratories.
Outsourcing-Pharma presents its weekly round-up of the latest chops and changes within the pharmaceutical jobs market, with news from Patheon, AmerisourceBergen and Premier Research.
SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.
The FDA has said it is critical that trade secret laws are changed to allow it to share manufacturing information with other regulators.
President Obama’s budget for 2013 projects FDA funding of $2.5bn (€1.9bn), flat year-on-year, but user fees will give it more cash.